No data extraction was performed due to the absence of useable data in the one eligible study. If there had been data to include, two review authors would have independently extracted the data from the studies using a data extraction form designed and pilot tested by the authors. Any disagreements would have been resolved by discussion or by a third review author.
Main results
Only one randomised controlled trial of endometrial polypectomy was identified for inclusion. However, a single set of data could not be extracted from this study due to internal inconsistencies of the results reported. Attempts to contact the authors to resolve the issue were unsuccessful, by phone, post and e-mail.
Authors' conclusions
Removal of endometrial polyps in subfertile women is commonly being performed in many countries with an aim to improve the reproductive outcome. We did not identify any analysable randomised trials which would allow us to reach any sound scientific conclusions on the efficacy of endometrial polypectomy in subfertile women. Well designed, methodologically sound, randomised controlled trials are urgently needed.
P L A I N L A N G U A G E S U M M A R Y

Removal of endometrial polyps prior to infertility treatment
Review question
Cochrane authors investigated whether the removal of endometrial polyps in women presenting with subfertility was safe and whether it improved the chance of pregnancy.
Background
Endometrial polyps, which are benign and often asymptomatic growths of the lining of the womb, have the potential to interfere with female fertility. This can be due to alteration of the micro-environment of the womb or due to physical interference with sperm transport impeding fertilization and subsequent implantation of the embryo. Diagnosis of these growths is mainly through using ultrasound during routine investigations prior to treatment for infertility. Removal of these polyps prior to embarking on any fertility treatment has been suggested as a way to improve the overall outcome of the treatment.
Study characteristics
The authors did not identify any analysable studies that were of sufficient quality to draw any conclusions. The searches are current to July 2014.
Key results and quality of evidence
Due to the lack of available randomised evidence, the authors of this review are unable to draw any conclusions on the routine removal of endometrial polyps prior to treatments for infertility. To answer this question, large and well designed studies are required.
B A C K G R O U N D
Description of the condition
Endometrial polyps are localized overgrowths of uterine mucosa that are of unknown aetiology. They may result from altered expression of the estrogen receptor in the endometrium, leading to excessive local endometrial growth in response to circulating estrogen. The polyps are commonly associated with irregular or abnormal ovulation (Lopez 2007; Mittal 1996) and are made up of irregular proliferative glands and stroma around a vascular pedicle originating from a spiral artery. Diagnosis is usually by transvagi-nal ultrasound, hysterosalpingography or saline infusion sonography, although the gold standard strategy is hysteroscopy (Taylor 2008). They are mostly asymptomatic but there is evidence in subfertile women that polyps may adversely affect fertility, although the mechanism is poorly understood (Taylor 2008). Proposed mechanisms include mechanical interference with sperm transport; anatomical interference with implantation (Spiewankiewicz 2003); increased production of inhibitory factors such as glycodelin, which can inhibit natural killer cell function (Richlin 2002); reduced secretion of implantation factors such as insulinlike growth factor-binding protein-1 (IGFBP-1), tumour necrosis factor (TNF-alpha) and osteopontin (Ben-Nagi 2009); and unresponsiveness to cyclical hormonal changes (Mittal 1996) . It is plausible that removal of the polyps might improve fertility. Subfertility is defined as failure to achieve a clinical pregnancy despite regular unprotected sexual intercourse for 12 months or more.
Description of the intervention
Polypectomy under general anaesthesia; or in an office setting performed without direct visualisation using a transcervical sharp curette; or hysteroscopy-directed polypectomy using scissors, a loop electrode, electric probe or a morcellator (Taylor 2008).
How the intervention might work
Polypectomy reverses mechanical and anatomical distortions within the uterine cavity and this may potentially improve the chances of embryo implantation and a successful pregnancy outcome. A recent study has shown that the levels of endometrial implantation factors, such as mid-secretory concentrations of IGFBP-1, TNFa and osteopontin, are increased following the surgical removal of polyps (Ben-Nagi 2009). The increase in these implantation factors enhances the implantation rates.
Why it is important to do this review
Embryo implantation is a critical step in achieving a successful pregnancy and involves a series of complex interactions between the developing blastocyst and the endometrium. A normal endometrium, physiologically and structurally, is essential and physiological and structural abnormalities may lead to adverse reproductive outcomes. While physiological abnormalities of the endometrium are mostly unresponsive to therapeutic manipulation, structural abnormalities such as uterine fibroids, endometrial polyps, intrauterine adhesions and Mullerian anomalies are potentially amenable to surgical treatment. Endometrial polyps are the most common structural abnormalities, with the prevalence ranging from 10% in asymptomatic women to 26% in women with unexplained subfertility (de Sa Rosa e de Silva 2005) and up to 47% in women with endometriosis-associated subfertility (Kim 2003) . Subfertility has significant psychological and financial implications for a couple. As polyps are relatively frequent in subfertile women, most clinicians recommend removal prior to commencement of any fertility treatment. However, there is no robust evidence to support this and the procedure has risks of uterine perforation, bleeding, and infection together with associated anaesthetic risks. It is important to provide evidence-based recommendations for the treatment of endometrial polyps in subfertile women.
O B J E C T I V E S
The aim of this review was to determine the effectiveness and safety of removal of endometrial polyps in subfertile women.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) in which polyps were removed surgically for the treatment of subfertility. Only trials that were either clearly randomised or claimed to be randomised and did not have evidence of inadequate sequence generation were eligible for inclusion.
Types of participants
Women with subfertility of more than 12 months' duration and who were diagnosed with one or more endometrial polyps detected by transvaginal ultrasound, hysterosalpingography, saline infusion sono-hysterography or hysteroscopy.
Types of interventions
• Surgical removal of endometrial polyps by any technique • Expectant management as the control
Types of outcome measures
Primary outcomes
1. Live birth rates 2. Reported surgical complications (e.g. infection; bleeding; injury to uterus, bowel, bladder, blood vessels)
Secondary outcomes
1. Clinical pregnancy rates (evidence of pregnancy by ultrasound visualization of a gestational sac) 2. Ongoing pregnancy rates 3. First trimester miscarriage 4. Second trimester miscarriage 5. Preterm delivery
Search methods for identification of studies Electronic searches
The search strategy was designed in consultation with the Menstrual Disorders and Subfertility Group (MDSG) Trials Search Co-ordinator. We searched the following electronic databases with no language restriction, from inception to the present with the Cochrane highly sensitive search strategy for identifying randomised trials that appears in the Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0, chapter 6, 6.4.11). 1. Cochrane MDSG Specialised Register (from inception to present).
Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, latest issue).
3. The English language electronic databases MEDLINE, EM-BASE and PsycINFO. 4. The Cochrane Library (http://www.thecochranelibrary.com) for the Database of Abstracts of Reviews of Effects (DARE) (nonCochrane reviews on similar topics). 5. Current Controlled Trials (www.controlled-trials.com). 6. World Health Organization International Clinical Trials Registry Platform search portal (www.who.int/trialsearch/ Default.aspx).
Searching other resources
We performed a search of the references lists of all included studies and relevant reviews to identify further relevant articles. We have contacted the authors and experts in the relevant field to aid in identification of potential studies. The data contained within this review are current to July 2014.
Data collection and analysis
We planned to perform the statistical analysis in accordance with the Cochrane Handbook for Systematic Reviews of Interventions and to use Review Manager 5.1 for input and analysis of data.
Selection of studies
The title, abstract and keywords of every record retrieved were scrutinized independently by two review authors to determine which studies required further assessment. The full text was retrieved when the information given in the titles, abstracts and keywords suggested that the study was randomised and the intervention was a surgical polypectomy. If there were any doubts regarding whether the study met the criteria for inclusion from scanning the titles and abstracts, the full article was retrieved for clarification. Disagreements were resolved by discussion with a third review author, when necessary. We attempted to contact the authors of potentially eligible trials in order to obtain missing data.
Data extraction and management
No data extraction was performed due to the absence of eligible studies. If eligible studies are found when updating this review, two review authors will independently extract the data from these studies using a data extraction form designed and pilot tested by the authors. Any disagreements will be resolved by discussion or by a third review author. Where studies have multiple publications, the main trial report will be used as the reference and additional details supplemented from the secondary papers.
Assessment of risk of bias in included studies
We planned that risk of bias would be assessed using the Cochrane Collaboration tool for assessing risk of bias. We planned that two review authors would independently perform assessment of risk of bias in the included studies; disagreements would be noted and resolved by a third review author. We planned that the risk of bias table would be included in the table 'Characteristics of included studies'. The following risk of bias domains were to be assessed according to the quality criteria specified by the Cochrane Handbook for Systematic Reviews of Interventions 5.1.0. 1. Sequence generation: low risk of bias, method clearly described (e.g. computer generated, random number tables, or drawing lots); unclear risk of bias, methods not fully described. 2. Allocation concealment: low risk of bias, method clearly described in detail (e.g. third party, sealed opaque consecutively numbered envelopes); high risk of bias (e.g. open list of allocation codes); unclear risk of bias (e.g. not stated). 3. Blinding of outcome assessors. 5. Completeness of outcome data. 6. Selective outcome reporting. 7. Any other sources of potential bias identified.
Measures of treatment effect
We planned that collected data would be dichotomous. The numbers of events in the control and intervention groups of each study would be used to calculate Peto odds ratios, and 95% confidence intervals will be presented for all outcomes.
Unit of analysis issues
We planned that the primary unit of analysis would be per woman randomised and not per cycle.
Dealing with missing data
We planned that the data would be analysed on an intentionto-treat basis (that is analysing all randomised participants in the original randomly assigned groups), as far as possible. We planned to contact the authors of the RCTs to source any missing data or to resolve any queries that might arise. If the participant numbers randomised and the numbers analysed were inconsistent we planned to use the data available, and the percentage loss to follow up would be calculated and reported in the 'Characteristics of included studies' table.
Assessment of heterogeneity
We planned to assess clinical heterogeneity and to carry out tests for statistical heterogeneity using the Chi 2 test, with significance set at P < 0.1. We planned to use the I 2 statistic to estimate the total variation across studies that was due to heterogeneity, with a value < 25% considered as low level, 25% to 50% as moderate level, and > 50% as high level heterogeneity. If high levels of heterogeneity (I 2 > 50%) were seen for the primary outcomes, we planned to explore possible sources of heterogeneity using sensitivity analyses.
Assessment of reporting biases
We planned to assess potential publication bias using a funnel plot, or other corrective analytical methods, if there were sufficient included studies (10 or more).
Data synthesis
We planned that a meta-analysis would be performed if the included studies were sufficiently similar. As all the planned outcomes were dichotomous variables, the results would be expressed as odds ratios (OR) with 95% confidence intervals (CI), calculated using Review Manager 5. As we anticipated heterogeneity amongst studies, we planned to use a the random-effects model with inverse variance weighting. This method incorporates heterogeneity in the analysis of the overall efficacy of treatment by making adjustments to the study weights according to the extent of variation.
Subgroup analysis and investigation of heterogeneity
We planned to perform the following subgroup analyses. 1. Efficacy of surgical polypectomy in women treated with ovulation induction and timed intercourse. 2. Efficacy of surgical polypectomy in women treated with intrauterine insemination (IUI). 3. Efficacy of surgical polypectomy in women treated with in vitro fertilization treatment. 4. Efficacy of different surgical methods of polypectomy versus conservative management. 5. Efficacy of surgical polypectomy depending on polyp sizes (< 1 cm, 1 to 2 cm and > 2 cm). 6. Efficacy of surgical polypectomy in women undergoing differing assisted reproduction treatments. We planned to perform subgroup analysis only if there were a substantial number of studies in each subgroup. Factors such as age, length of follow up and adjusted or unadjusted analysis would be considered in the interpretation of any heterogeneity.
Sensitivity analysis
We planned to perform sensitivity analyses by repeating the analysis in order to explore the influence of the following factors on effect size: 1. restriction of analysis to published studies; 2. restriction of analysis to high quality studies, with adequate reporting of allocation methods, blinding and numbers lost to follow up.
Overall quality of the body of evidence: summary of findings table
We planned to prepare a summary of findings table using Guideline Development Tool software. This table would evaluate the overall quality of the body of evidence for the main review outcomes (live birth, complications and clinical pregnancy) using the GRADE criteria (study limitations (that is risk of bias), consistency of effect, imprecision, indirectness and publication bias). Judgements about evidence quality (high, moderate or low) would be justified, documented and incorporated into reporting of results for each outcome.
R E S U L T S Description of studies
Results of the search
The electronic search was conducted on 30 July 2014 and a total of 306 citations were identified. From these, 10 studies were read in their entirety. The study selection flow diagram is shown in Figure 1 . 
Included studies
Only one relevant randomised trial was found (Perez-Medina 2005). However, no results can be presented because we could not extract a single set of results. Specifically, we could not resolve the internal inconsistencies reported. 1. In the results section of the paper (paragraph 6, page 1634) a 51% pregnancy rate in the treatment (study) group and 25% in the control group after four cycles of IUI were reported. However, Kaplan-Meier survival analysis curves (Figure 1 of the paper on the same page) show higher 'survival' in the treatment group than in the control group. The Y axis on the figure is not labelled, but if we assume the Y axis indicates 'survival' and 'survival' means participants remain non-pregnant after each IUI cycle, then figure 1 is showing a lower pregnancy rate in the treatment group than in the control group. 2. In paragraph 3, page 1634, it was stated that 11 patients were excluded post-randomisation. In one section of the same sentence it was implied they were all lost to follow up. In another it was stated that four (three treatment, one control) were lost to follow up, that three (one treatment, two control) were excluded because a polyp was not confirmed on histology, and four (two treatment, two control) because the pathology report showed a myoma. The reasons for excluding these latter four (or seven) are unclear. Attempts by phone, e-mail and post to contact the authors to resolve these queries were unsuccessful. Accordingly we concluded that we could not present any data.
Excluded studies
We excluded 9 controlled studies that we identified. Two of the potential articles were retrospective case control studies 
Risk of bias in included studies
Allocation
Random sequence generattion
We assessed Perez-Medina 2005 as at low risk of this bias, as a computerised random number table was used.
Allocation concealment
We assessed Perez-Medina 2005 as at unclear risk of this bias; the authors state they used 'an opaque envelope technique' but do not mention numbering of the envelopes.
Blinding
We felt the trial was at unclear risk of these biases, owing to insufficient information apart from the statement that all hysteroscopies were performed by the same clinician.
Incomplete outcome data
We could not reconcile the attrition data reported by the trial authors so assessed this risk as unclear.
Selective reporting
At least one outcome of interest was reported incompletely so data could not be entered into a meta-analysis. We assessed this risk as high.
Other potential sources of bias
Table I of the study shows some significant differences between the intervention and control groups at baseline, suggesting a potential source of bias related to the study design. In addition the trial authors have stated that the majority of pregnancies occurred before the IUI took place. We consider the trial at high risk of this bias.
Effects of interventions
We were unable to extract data for any of the outcomes reported in Perez-Medina 2005, so there are no results to present in this review.
D I S C U S S I O N
Summary of main results
We found no eligible randomised controlled trials (RCTs) comparing hysteroscopic removal of endometrial polyps with expectant management in determining the effectiveness and safety of removal of endometrial polyps in subfertile women that had relevant data for inclusion. The one relevant RCT identified had internal inconsistencies in the results reported. In view of the lack of data, no sound scientific conclusions can be drawn on the efficacy and safety of endometrial polypectomy in subfertile women diagnosed to have endometrial polyps. Nevertheless, hysteroscopic removal of endometrial polyps in women with subfertility is commonly practiced considering that it is a minor in-patient or out-patient procedure. While its efficacy and safety have been favourably reported in many controlled studies, a sound evidence-based conclusion could not be drawn due to the lack of data from any well conducted RCTs.
Potential biases in the review process
All steps of the review process were conducted in accordance with the Cochrane Handbook for Systematic Reviews of Interventions in order to minimize potential bias. Our searches were comprehensive.
Agreements and disagreements with other studies or reviews
A recent systematic review (Afifi 2010) included retrospective studies and, due to the heterogeneity of the data, the authors were unable to draw any conclusions regarding the effectiveness of polypectomy on the outcomes of artificial reproductive treatments (ART). However, the authors of the review suggested that women should be advised on hysteroscopy and contemporaneous polypectomy prior to embryo replacement if an endometrial polyp was identified.
A U T H O R S ' C O N C L U S I O N S Implications for practice
There is no evidence on the efficacy and safety of removal of endometrial polyps in subfertile women to support the routine practice of surgical intervention for endometrial polyps that are incidentally found while evaluating women for subfertility. On the other hand, the procedure is minimally invasive and hysteroscopic polypectomy provides an opportunity for a histological diagnosis. We have been unable to substantiate external evidence that endometrial injury during hysteroscopy prior to in vitro fertilization (IVF) treatment improves the chances of live births. Well designed, methodologically sound, randomised controlled trials are warranted to provide evidence-based recommendations on managing endometrial polyps in subfertile women.
No good quality data exist supporting the routine treatment of endometrial polyps that are identified while women are undergoing artificial reproductive treatments (ARTs) such as IVF or intracytoplasmic sperm injection (ICSI).
When endometrial malignancy arising from the polyp is suspected, appropriate investigations and treatment should be carried out without undue delay and in accordance with local guidelines.
Implications for research
Due to the paucity of available good quality data, many uncertainties and clinical queries exist. Besides the primary research question of whether endometrial polypectomy is effective and safe in subfertile women, there are various associated clinical dilemmas that need answers. What is the optimal timing of endometrial polypectomy? Is there a size effect and should every polyp be removed irrespective of size? If a polyp is identified during controlled ovarian stimulation, should it be removed and the embryo transfer deferred to another cycle? What is the effect of polypectomy on the treatment outcome of fresh IVF and ICSI cycles and frozen embryo replacement cycles? What is the effect of polypectomy on implantation rates, miscarriage rates, multiple pregnancy rates, and pregnancy complication rates? What is the complication rate of polypectomies in the subfertile population?
All these questions need to be answered by means of a well designed, large, randomised controlled trial. It is also worth investigating if just the physical injury to the endometrium performed while sampling the polyp to exclude dysplasia or malignancy, without complete polypectomy, can elicit a favourable or at least similar cycle outcome when compared to the intervention or placebo treatment. Data from studies where endometrial biopsy has been performed prior to ART in women with no endometrial pathology seem to support the last notion (Nastri 2012). However, the presence of the polyp might negate this benefit and the relationship should be further investigated.
A C K N O W L E D G E M E N T S
We thank Jane Clarke (former Managing Editor), Helen Nagels (Managing Editor), Marian Showell (Trials Search Co-ordinator) and the editorial board of the Cochrane MDSG for their invaluable assistance in developing this review.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Perez-Medina 2005
Methods
Patients were randomized to one of the two groups with use of an opaque envelope technique, with assignment determined by a computerized random number 
Interventions
The study group was composed of 107 women; the polypectomy was performed using rigid 5 Fr scissors and forceps during office hysteroscopy. When resection was not possible during the diagnostic hysteroscopy, the patient was scheduled for operative hysteroscopy under anaesthesia The control group was composed of 108 women in whom only a biopsy of the polyp was performed during a diagnostic hysteroscopy Women were scheduled to receive four cycles of IUI, and the first IUI was planned for three cycles after hysteroscopy in both groups Outcomes Clinical pregnancy demonstrated on a TVUS 30 days after IUI was the main outcome measure analysed to determine the effectiveness of treatment. We studied the crude pregnancy rate in both groups. The secondary outcomes were to compare the time for success in each group and to determine whether the size of the EP influenced the pregnancy rate Notes Some pregnancies were the result of a spontaneous conception in the interim period between hysteroscopy and IUI
Risk of bias
Bias
Authors' judgement Support for judgement
Random sequence generation (selection bias)
Low risk "Patients were randomized to one of the two groups with use of an opaque envelope technique, with assignment determined by a computerized random number table." "Subjects were randomized into one of two groups in a 1:1 ratio using a restricted randomization." Menstrual Disorders and Subfertility Group search strategy for BM623 Keywords CONTAINS "polyp removal" or "polypectomy" or "polyps"or "uterine polyps"or "endometrial polyps" or Title CON-TAINS"polyp removal" or "polypectomy" or "polyps"or "uterine polyps"or "endometrial polyps"
